News and Newsletters

Newsletters >
3 November 2011
BAC and GE Healthcare expand product offering with the addition of VIISelect Bioprocess media
16 August 2011
BAC BV collaborates in providing custom CaptureSelect® affinity ligands for Bristol-Myers Squibb’s Adnectin™ biotherapeutics
1 August 2011
PhyNexus and BAC BV launch full range of CaptureSelect resins in PhyTip column format
21 June 2011
BAC BV collaborates with Life Technologies to provide new HPLC affinity columns
1 November 2010
BAC BV and BioSystem Development collaborate to bring industry-leading purification ligands to high throughput biotherapeutic process development.
29 September 2010
BAC completes feasibility study in providing unique selective ligands for Genmab’s UniBody® platform
16 September 2010
BAC launches CaptureSelect® HumanPlasma14 for depletion of abundant proteins from human blood plasma or serum
17 August 2010
BAC and Octapharma extend collaboration for G-CSF custom ligand for commercial scale manufacture
13 April 2010
BAC Affinity Ligand Licensed for Clinical and Commercial Scale-up of LFB Biotechnologies’ Recombinant Factor VIIa
17 February 2010
BAC Extends Partnership with GE Healthcare to Launch Alpha-1 Antitrypsin Select
2 November 2009
BAC BV expands alliance with Octapharma Group for the purification of recombinant proteins
3 November 2008
BAC expands collaboration with GE Healthcare with launch of KappaSelect
28 May 2008
BAC and LFB to develop ligand for Purifying Recombinant Factor VIIa
21 April 2008
BAC adds IgM and IgA matrices to its CaptureSelect® Toolbox
20 March 2008
BAC signs license agreement with Hematech
13 March 2008
BAC and Octapharma to develop custom ligand for recombinant plasma protein
12 November 2007
BAC launches CaptureSelect® toolbox for antibody purification
7 May 2007
BAC announces collaboration with Sanofi Pasteur
2 April 2007
BAC and GE Healthcare announce FVIII purification media development
19 October 2006
GE healthcare and BAC announce strategic collaboration